To accomplish this, we employed cannabidiol as a pharmacological tool to activate TRPV2 in breast cancer cells, and extra Fluo-4 labeled calcium buffer were applied to monitor and track the dynamic changes in calcium levels within the cellular context [48, 49]. The gene discussed is TRPV2; the disease is breast carcinoma.